Showing results (271-280 of 427) with videos related to
Sort By:
Pageof 43
Science (New York, N.Y.)|June 4, 2021
Estimating epidemiologic dynamics from cross-sectional viral load distributionsJames A Hay, Lee Kennedy-Shaffer, Sanjat Kanjilal, et al.The Journal of Infectious Diseases|June 7, 2018
Impact of Antimicrobial Treatment for Acute Otitis Media on Carriage Dynamics of Penicillin-Susceptible and Penicillin-Nonsusceptible Streptococcus pneumoniaeJoseph A Lewnard, Paula A Tähtinen, Miia K Laine, et al.Journal of Medical Internet Research|September 14, 2019
Interaction Patterns of Men Who Have Sex With Men on a Geosocial Networking Mobile App in Seven United States Metropolitan Areas: Observational StudyNadia N Abuelezam, Yakir A Reshef, David Novak, et al.Scientific Reports|March 3, 2019
Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure doseKate E Langwig, M Gabriela M Gomes, Mercedes D Clark, et al.BMJ (Clinical Research Ed.)|May 20, 2021
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort studySarah E Daugherty, Yinglong Guo, Kevin Heath, et al.The Medical Journal of Australia|August 4, 2009
Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpileJames M McCaw, James G Wood, Emma S McBryde, et al.MMWR. Morbidity and Mortality Weekly Report|June 23, 2022
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022Deborah E Malden, Vennis Hong, Bruno J Lewin, et al.JMIR Public Health and Surveillance|January 6, 2021
Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the PandemicSharon K Greene, Sarah F McGough, Gretchen M Culp, et al.Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Estimating epidemiologic dynamics from cross-sectional viral load distributionsJames A Hay, Lee Kennedy-Shaffer, Sanjat Kanjilal, et al.Lancet (London, England)|November 10, 2021
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational studyNoam Barda, Noa Dagan, Cyrille Cohen, et al.Pageof 43